Skip to main content
Top
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Research article

Health-related quality of life in multiple sclerosis: temperament outweighs EDSS

Authors: S. Salhofer-Polanyi, F. Friedrich, S. Löffler, P. S. Rommer, A. Gleiss, R. Engelmaier, F. Leutmezer, B. Vyssoki

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

The influence of personality on health-related quality of life in patients with multiple sclerosis has been the focus of previous studies showing that introversion and neuroticism were related with reduced health related quality of life. However, no data exist on the impact of temperament on quality of life in this patient group.

Methods

Between April 2014 and March 2016 139 multiple sclerosis patients were recruited from a specialized outpatient clinic of the general hospital of Vienna. Health-related quality of life was measured by “The Multiple Sclerosis International Quality of Life Questionnaire (MusiQol)”, temperament by “Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Questionnaire – Münster version” (briefTEMPS-M), and disability by the “Expanded disability status scale”. All patients underwent a diagnostic psychiatric semi-structured interview (MINI).

Results

Known predictors (like disease duration, EDSS, psychiatric co-morbidities, immunomodulatory treatments) explain the proportion of variation in the outcome of MusiQol global index score in 30.9% in multi-variable linear regression analysis. It increased respectively to 40.3, 42.5, and 45.8% if adding the depressive, cyclothymic, or hyperthymic temperament to the list of variables. An increase of depressive and cyclothymic temperament scores significantly reduced global index score of MusiQol (p = 0.005, p = 0.002, respectively), while the hyperthymic temperament significantly raised it (p < 0.001).

Conclusion

In MS patients, the depressive and cyclothymic temperament predict a lower and hyperthymic temperament an increased health-related quality of life, independent of current disability status, immunomodulatory treatments, and affective co-morbidities.
Appendix
Available only for authorised users
Literature
2.
go back to reference Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1–2):29–34.CrossRefPubMed Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1–2):29–34.CrossRefPubMed
3.
go back to reference Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, et al. Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci. 2009;30(1):15–20.CrossRefPubMed Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, et al. Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci. 2009;30(1):15–20.CrossRefPubMed
4.
go back to reference Yamout B, Issa Z, Herlopian A, El Bejjani M, Khalifa A, Ghadieh AS, et al. Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis. Eur J Neurol. 2013;20(5):756–64.CrossRefPubMed Yamout B, Issa Z, Herlopian A, El Bejjani M, Khalifa A, Ghadieh AS, et al. Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis. Eur J Neurol. 2013;20(5):756–64.CrossRefPubMed
5.
go back to reference Benedict RH, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci. 2001;13(1):70–6.CrossRefPubMed Benedict RH, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci. 2001;13(1):70–6.CrossRefPubMed
6.
go back to reference Christodoulou C, Deluca J, Johnson SK, Lange G, Gaudino EA, Natelson BH. Examination of Cloninger's basic dimensions of personality in fatiguing illness: chronic fatigue syndrome and multiple sclerosis. J Psychosom Res. 1999;47(6):597–607.CrossRefPubMed Christodoulou C, Deluca J, Johnson SK, Lange G, Gaudino EA, Natelson BH. Examination of Cloninger's basic dimensions of personality in fatiguing illness: chronic fatigue syndrome and multiple sclerosis. J Psychosom Res. 1999;47(6):597–607.CrossRefPubMed
7.
go back to reference Merkelbach S, Konig J, Sittinger H. Personality traits in multiple sclerosis (MS) patients with and without fatigue experience. Acta Neurol Scand. 2003;107(3):195–201.CrossRefPubMed Merkelbach S, Konig J, Sittinger H. Personality traits in multiple sclerosis (MS) patients with and without fatigue experience. Acta Neurol Scand. 2003;107(3):195–201.CrossRefPubMed
8.
go back to reference Kraepelin E. 100 years of psychiatry. Vertex. 2010;21(91):317–20.PubMed Kraepelin E. 100 years of psychiatry. Vertex. 2010;21(91):317–20.PubMed
9.
go back to reference Akiskal KK, Akiskal HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord. 2005;85(1–2):231–9.CrossRefPubMed Akiskal KK, Akiskal HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord. 2005;85(1–2):231–9.CrossRefPubMed
10.
go back to reference Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, Gillin JC, et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. 2005;85(1–2):45–52.CrossRefPubMed Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, Gillin JC, et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. 2005;85(1–2):45–52.CrossRefPubMed
11.
go back to reference Ozkan A, Altinbas K, Koc ER, Sen HM, Ozisik Karaman HI. Affective temperament profiles in patients with multiple sclerosis: association with mood disorders. Noro Psikiyatr Ars. 2016;53(4):311–6.CrossRefPubMed Ozkan A, Altinbas K, Koc ER, Sen HM, Ozisik Karaman HI. Affective temperament profiles in patients with multiple sclerosis: association with mood disorders. Noro Psikiyatr Ars. 2016;53(4):311–6.CrossRefPubMed
12.
go back to reference Gazioglu S, Cakmak VA, Ozkorumak E, Usta NC, Ates C, Boz C. Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics. J Nerv Ment Dis. 2014;202(5):408–11.CrossRefPubMed Gazioglu S, Cakmak VA, Ozkorumak E, Usta NC, Ates C, Boz C. Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics. J Nerv Ment Dis. 2014;202(5):408–11.CrossRefPubMed
13.
go back to reference Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.CrossRefPubMedPubMedCentral
14.
go back to reference Flachenecker P, Vogel U, Simeoni MC, Auquier P, Rieckmann P. MusiQol: international questionnaire investigating quality of life in multiple sclerosis: validation results for the German subpopulation in an international comparison. Nervenarzt. 2011;82(10):1281–9.CrossRefPubMed Flachenecker P, Vogel U, Simeoni MC, Auquier P, Rieckmann P. MusiQol: international questionnaire investigating quality of life in multiple sclerosis: validation results for the German subpopulation in an international comparison. Nervenarzt. 2011;82(10):1281–9.CrossRefPubMed
15.
go back to reference Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS. Studies on a German (Munster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS-M. J Affect Disord. 2005;85(1–2):53–69.CrossRefPubMed Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS. Studies on a German (Munster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS-M. J Affect Disord. 2005;85(1–2):53–69.CrossRefPubMed
16.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 4-57PubMed Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 4-57PubMed
18.
go back to reference Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.CrossRefPubMed Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.CrossRefPubMed
19.
go back to reference Heinze G, Schemper M. Comparing the importance of prognostic factors in cox and logistic regression using SAS. Comput Meth Prog Bio. 2003;71(2):155–63.CrossRef Heinze G, Schemper M. Comparing the importance of prognostic factors in cox and logistic regression using SAS. Comput Meth Prog Bio. 2003;71(2):155–63.CrossRef
20.
go back to reference Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482–6.CrossRefPubMed Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482–6.CrossRefPubMed
21.
go back to reference Planche V, Moisset X, Morello R, Dumont E, Gibelin M, Charre-Morin J, et al. Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: a 3-year follow-up multicentric study. J Neurol Sci. 2017;382:148–54.CrossRefPubMed Planche V, Moisset X, Morello R, Dumont E, Gibelin M, Charre-Morin J, et al. Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: a 3-year follow-up multicentric study. J Neurol Sci. 2017;382:148–54.CrossRefPubMed
22.
go back to reference von Zerssen D, Akiskal HS. Personality factors in affective disorders: historical developments and current issues with special reference to the concepts of temperament and character. J Affect Disord. 1998;51(1):1–5.CrossRefPubMed von Zerssen D, Akiskal HS. Personality factors in affective disorders: historical developments and current issues with special reference to the concepts of temperament and character. J Affect Disord. 1998;51(1):1–5.CrossRefPubMed
23.
go back to reference Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305–17.CrossRefPubMedPubMedCentral Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305–17.CrossRefPubMedPubMedCentral
24.
go back to reference Erdogan Taycan S, Taycan O. Affective temperament profiles and clinical correlates in patients with epilepsy: a link from mood disorders. J Affect Disord. 2014;164:1–4.CrossRefPubMed Erdogan Taycan S, Taycan O. Affective temperament profiles and clinical correlates in patients with epilepsy: a link from mood disorders. J Affect Disord. 2014;164:1–4.CrossRefPubMed
25.
go back to reference Zarbo IR, Minacapelli E, Falautano M, Demontis S, Carpentras G, Pugliatti M. Personality traits predict perceived health-related quality of life in persons with multiple sclerosis. Mult Scler. 2016;22(4):551–8.CrossRefPubMed Zarbo IR, Minacapelli E, Falautano M, Demontis S, Carpentras G, Pugliatti M. Personality traits predict perceived health-related quality of life in persons with multiple sclerosis. Mult Scler. 2016;22(4):551–8.CrossRefPubMed
26.
go back to reference Benedict RH, Wahlig EL, Topciu RA, Englert J, Schwartz E, Chapman B, et al. Personality traits in women with multiple sclerosis: discrepancy in patient/partner report and disease course. J Psychosom Res. 2009;66(2):147–54.CrossRefPubMed Benedict RH, Wahlig EL, Topciu RA, Englert J, Schwartz E, Chapman B, et al. Personality traits in women with multiple sclerosis: discrepancy in patient/partner report and disease course. J Psychosom Res. 2009;66(2):147–54.CrossRefPubMed
27.
go back to reference Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, et al. Cortical atrophy and personality in multiple sclerosis. Neuropsychology. 2008;22(4):432–41.CrossRefPubMed Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, et al. Cortical atrophy and personality in multiple sclerosis. Neuropsychology. 2008;22(4):432–41.CrossRefPubMed
28.
go back to reference Tur C, Tintore M, Vidal-Jordana A, Bichuetti D, Nieto Gonzalez P, Arevalo MJ, et al. Risk acceptance in multiple sclerosis patients on natalizumab treatment. PLoS One. 2013;8(12):e82796.CrossRefPubMedPubMedCentral Tur C, Tintore M, Vidal-Jordana A, Bichuetti D, Nieto Gonzalez P, Arevalo MJ, et al. Risk acceptance in multiple sclerosis patients on natalizumab treatment. PLoS One. 2013;8(12):e82796.CrossRefPubMedPubMedCentral
Metadata
Title
Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
Authors
S. Salhofer-Polanyi
F. Friedrich
S. Löffler
P. S. Rommer
A. Gleiss
R. Engelmaier
F. Leutmezer
B. Vyssoki
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1719-6

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue